Transforming people’s lives through groundbreaking ideas

P53 invests in innovative healthcare companies, particularly in the businesses of biotechnology and medical devices. We seek to contribute to the development and commercialization of groundbreaking ideas that will increase accessibility to cutting-edge treatments and innovative solutions with positive effect on quality of life and well-being.

We work continuously to identify trends and finding companies that can create exceptional value.

Our companies are founded on strong science. P53 work closely with entrepreneurs to build competitive healthcare companies driven by outstanding knowledge, unique mindsets, integrity, and shared values.

In addition to long-term capital, P53 will make valuable contributions in the form of knowledge, experience, and networking through active ownership. All investments are made in line with TD Veen’s overall strategy and objective, where sustainable development and a scalable business model are particularly emphasized.

Contact:
Susanne Stuffers, CEO & Chief Investment Officer
+47 9119 4204
susanne@tdveen.no